Weightlifting linked to lower risk for all-cause, CVD mortality
Sep 30, 2022
Adults reporting weightlifting one to two times a week in addition to moderate-to-vigorous physical activity had the lowest risk.
More steps reduce risk for new cardiovascular events in older adults
Mar 08, 2023
Taking 500 more daily steps was associated with a 14% lower risk for cardiovascular disease event over 3.5 years.
More sitting tied to greater death risk in older women
Feb 29, 2024
The findings were seen for both all-cause and cardiovascular death.
Cardio, cardio + resistance training improve CVD risk profile at one year
Jan 31, 2024
No similar benefit was seen for resistance exercise alone in adults with overweight or obesity, however.
Herpes zoster linked to increased risk for cardiovascular disease events
Dec 02, 2022
The long-term risks for stroke and coronary heart disease increased for individuals with a history of herpes zoster versus those with no history of herpes zoster.
Inflammation, poverty have synergistic effect on mortality
Jan 17, 2024
Individuals with elevated C-reactive protein at 1.0 mg/dL and poverty had a greater risk for 15-year all-cause mortality.
‘Microtube’ pacemaker joins the no-lead wireless heart device pack for seniors
By
Aaron Dorman
Dec 05, 2023
A new wireless pacemaker design could be easier to use and could remove the “healthcare burden” associated with maintenance, researchers say.
Disparities persist in CVD mortality, despite overall decline
Feb 28, 2023
Mortality was highest in rural counties and counties with a higher percentage of Black residents.
CVD mortality similar with diuretic, ACE inhibitor, or calcium channel blocker
Dec 04, 2023
Those randomly assigned to receive ACE inhibitor had an increased risks for stroke mortality and fatal and nonfatal hospitalized stroke versus the diuretic group.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.